Skip to content

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

Feasibility of Light Therapy in the Pediatric ICU

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07384585
Enrollment
30
Registered
2026-02-03
Start date
2026-03-26
Completion date
2027-01-01
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Dysregulation, Light Exposure, Pediatric Critical Illness

Brief summary

The goal of this clinical trial is to understand how easy or difficult it is for critically ill children (4-17 years old) to have light therapy while in the pediatric ICU. Participants will have a light meter at their bedside to measure light levels. Each morning, a light box will be placed at their bedside. Children, family, and staff will be asked to completed feedback surveys regarding the light therapy. Study participation will continue for a maximum of 5 days.

Interventions

OTHERLight Therapy

Light therapy will be delivered via a light box for a maximum of 5 days in the pediatric ICU. Light therapy will be initiated 1 to 2 hours following participant's typical wake time, and continue for 3 hours. The light box light intensity is 10,000 lux with high blue light content (5,000 Kelvin). The light box blocks ultraviolet rays. The portable light box will be placed in front or to the side of the child at a distance of 2 feet. The light box can be moved with activity and turned off at any time if requested by the child, family, or staff.

Sponsors

Laura Beth Kalvas
Lead SponsorOTHER
Nationwide Children's Hospital
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Anticipated to remain admitted to the study hospital pediatric ICU for additional 48 hours * English-speaking parent/legally authorized representative available at the bedside

Exclusion criteria

* Patients unable to open their eyes to receive light therapy (Glasgow Coma Scale eye opening score of 1 or neuromuscular blockade) * Patients with contraindications to light therapy (e.g., migraines, retinal disease, diseases associated with retinal complications, blindness, bipolar disorder, seizure disorder, traumatic brain injury) * Suspected/identified neglect/abuse, Child Protective Services involvement, or ward of state * Children receiving palliative/end-of-life care * Unable to fit light box/cart in patient room

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of light therapy for children, families, and staff.Maximum of 5 days of light therapy.Feasibility of light therapy assessed via feedback surveys from children, families, and clinical staff.
Duration of light therapyMaximum of 5 days of light therapy.Hours of light therapy received per study day.

Secondary

MeasureTime frameDescription
Adverse side effects of light therapy.Maximum of 5 days of light therapy.For each day of light therapy, presence of commonly reported side effects of light therapy (e.g., headache, eye strain, nausea, agitation) will be monitored and recorded in a daily monitoring form. Unanticipated problems and reportable adverse side effects will be monitored and recorded in an adverse event form. Presence of side effects will be determined from speaking with the bedside nurse, parent/caregiver, and child, review of the electronic medical record, and child/family/staff feedback surveys.
Light levelsMaximum of 5 days of light therapy.Continuous bedside monitoring of light levels in lux via a light meter.

Countries

United States

Contacts

CONTACTLaura Beth Kalvas, PhD, RN
laurabeth.kalvas@nationwidechildrens.org614-304-1872

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026